Utilization of glucagon-like peptide-1 receptor agonists in children and adolescents in China: a real-world study.

Yan, Yilong; Gong, Ying; Jiang, Meizhu; Gao, Yiming; Guo, Shanshan; Huo, Jiping; Zhao, Zhigang; Li, Cao

Yan, Yilong; Gong, Ying; Jiang, Meizhu; Gao, Yiming; Guo, Shanshan; Huo, Jiping; Zhao, Zhigang; Li, Cao.

Afiliação

Yan Y; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Gong Y; Department of Clinical Pharmacology, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Jiang M; Department of Pharmacy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
Gao Y; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Guo S; Department of Clinical Pharmacology, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Huo J; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhao Z; Department of Clinical Pharmacology, School of Pharmaceutical Sciences, Capital Medical University, Beijing, China.
Li C; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Front Endocrinol (Lausanne) ; 14: 1170127, 2023.

Article em En | MEDLINE | ID: mdl-37383395

Assuntos

Estado Pré-Diabético; Adolescente; Adulto; Criança; Humanos; China/epidemiologia; Receptor do Peptídeo Semelhante ao Glucagon 1; Obesidade; Sobrepeso; Estados Unidos

Palavras-chave

GLP-1RA; adolescents; children; diabetes; obesity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans País/Região como assunto: America do norte / Asia Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google